Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Dystonia

3,4-dihydroxyphenylacetic acid has been researched along with Dystonia in 5 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Dystonia: An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77)

Research Excerpts

ExcerptRelevanceReference
"Two cases of severe dystonia and dyskinesia were treated with talipexole, a dopamine autoreceptor agonist, and the metabolites of dopamine, norepinephrine, and serotonin in cerebrospinal fluid (CSF) were determined."3.68Chronic treatment with talipexole dihydrochloride on abnormal involuntary movement in humans. ( Koga, I; Nishikawa, T; Tanaka, M; Tsuda, A; Uchida, Y; Yamada, S, 1990)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Augood, SJ1
Hollingsworth, Z1
Albers, DS1
Yang, L1
Leung, J1
Breakefield, XO1
Standaert, DG1
Dang, MT1
Yokoi, F1
McNaught, KS1
Jengelley, TA1
Jackson, T1
Li, J1
Li, Y1
Rotrosen, J1
Stanley, M1
Kuhn, C1
Wazer, D1
Gershon, S1
Nishikawa, T1
Yamada, S1
Tsuda, A1
Tanaka, M1
Koga, I1
Uchida, Y1
Stahl, SM1
Faull, KF1
Barchas, JD1
Berger, PA1

Other Studies

5 other studies available for 3,4-dihydroxyphenylacetic acid and Dystonia

ArticleYear
Dopamine transmission in DYT1 dystonia.
    Advances in neurology, 2004, Volume: 94

    Topics: 3,4-Dihydroxyphenylacetic Acid; Autoradiography; Basal Ganglia; Benzamides; Benzazepines; Binding Si

2004
Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia.
    Experimental neurology, 2005, Volume: 196, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Age of Onset; Animals; Brain; Chromatography, High Pressure Liquid;

2005
Experimental dystonia induced by quaternary-chlorpromazine.
    Neurology, 1980, Volume: 30, Issue:8

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Chlorpromazine; Corpus Striatum; Disease

1980
Chronic treatment with talipexole dihydrochloride on abnormal involuntary movement in humans.
    Clinical neuropharmacology, 1990, Volume: 13, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Azepines; Dopamine Agents; Dystonia; Homovanillic Acid; Humans

1990
CSF monamine metabolites in movement disorders and normal aging.
    Archives of neurology, 1985, Volume: 42, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Dyskinesia, Drug-Induced; Dystonia; Female; Glycols; Ho

1985